entity

protein

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about protein: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

13Connections

30Hypotheses

30Analyses

10Outgoing

3Incoming

0Experiments

20Debates

No AI portrait yet

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Outgoing (10)

Target	Relation	Type	Str
secondary structure	involved_in	process	0.95
protein folding	involved_in	process	0.95
amino acid sequence	involved_in	process	0.90
Alzheimer'S Disease	biomarker_for	disease	0.88
Distant Pqtl Effects	mediates	mechanism	0.88
NEURODEGENERATION	associated_with	disease	0.80
protein_quantitative_trait_loci	mediates	phenotype	0.80
PROTEOSTATIC INTEGRITY	regulates	process	0.80
ORGANELLE COMMUNICATION	regulates	process	0.80
NETWORK-LEVEL COMPUTATION	regulates	process	0.80

Incoming (3)

Source	Relation	Type	Str
biomarkers-gap-43-growth-associated-protein	describes	wiki	0.90
LncRNA	interacts_with	biomarker	0.80
NEMO	interacts_with	protein	0.70

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
eIF2α Phosphorylation Imbalance Creates Integrated Stress Re	0.896	als	-
J-protein substrate specificity codes enable HSP70 discrimin	0.840	protein-biochemistry	Do chaperones selectively recognize path
J-protein co-chaperone system mediates selective autophagy t	0.831	protein-biochemistry	Do chaperones selectively recognize path
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43	0.824	neurodegeneration	What are the mechanisms by which gut mic
NLRP3 inflammasome amplification across AD and PD proteinopa	0.800	multi	Cross-disease neurodegeneration mechanis

Stress-granule RNA-binding protein phase transition across A	0.780	multi	Cross-disease neurodegeneration mechanis
TDP-43 Proteinopathy as a Cross-Disease Pathological Substra	0.760	neurodegeneration	Cross-disease neurodegeneration mechanis
ASO-mediated reduction of toxic C9orf72 dipeptide repeat pro	0.760	neurodegeneration	Test
C9orf72 Hexanucleotide Repeat Dipeptide Repeat Proteins Inhi	0.738	neurodegeneration	Legacy Pre-Pipeline Hypothesis Import
Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Bl	0.735	-	What blood-brain barrier permeability ch
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides	0.718	neurodegeneration	Blood-brain barrier transport mechanisms
ISR/eIF2α~P Overflow Represses Synaptic Protein Synthesis Do	0.683	alzheimers	-
Matrix Metalloproteinase-9/TIMP-1 Ratio in CSF Identifies Pr	0.675	-	What blood-brain barrier permeability ch
Chronic ISR Activation Represses Axonal Protein Synthesis in	0.650	parkinsons	-
J-protein co-chaperone repertoire enables selective recognit	0.642	protein-biochemistry	Do chaperones selectively recognize path
Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Bl	0.640	-	What blood-brain barrier permeability ch
Optogenetic PV Cell Activation Restores Gamma Power via PV P	0.635	alzheimers	Closed-loop optogenetic targeting PV int
Pericyte senescence is sufficient to weaken the BBB even wit	0.630	neurodegeneration	Does pericyte senescence drive BBB break
ATXN2 Antisense Oligonucleotides Reduce Dipeptide Repeat Pro	0.630	neurodegeneration	Test
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Biophysical Determinants Shifting FUS/TD
RNA-Binding Protein Sequestration and 3′UTR Dysregulation	0.625	-	How does the intron-retained RNA isoform
Heat Shock Protein 70 Disaggregase Amplification	0.625	neurodegeneration	TDP-43 phase separation therapeutics for
Serine/Arginine-Rich Protein Kinase Modulation	0.624	neurodegeneration	TDP-43 phase separation therapeutics for
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m	0.621	neurodegeneration	Mitochondrial transfer between astrocyte
Tau fibrils expose neuronal phosphatidylserine and heat-shoc	0.620	neurodegeneration	Synaptic pruning by microglia in neurode
CSF ApoE- and clusterin-rich lipoprotein particles stabilize	0.606	neurodegeneration	Which specific CSF molecular components
TREM2-mediated PV interneuron stabilization to restore gamma	0.583	neurodegeneration	-
A genetically encoded reporter for axonal mitochondrial prot	0.565	neuroscience	How can subcellular compartmentalization
eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote	0.000	als	-

Mentioning Analyses (30)

Scientific analyses that reference this entity

Proteogenomic Network Hubs as Druggable Targets in Early PD Neurodegeneration

neurodegeneration | 2026-04-27 | 3 hypotheses Top: 0.626

m6A RNA Modification and Alpha-Synuclein Aggregation in Substantia Nigra

neurodegeneration | 2026-04-27 | 4 hypotheses Top: 0.662

How does the intron-retained RNA isoform mechanistically reduce glucocerebrosida

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.645

What are the mechanisms by which microglial senescence contributes to ALS pathol

neurodegeneration | 2026-04-26 | 12 hypotheses Top: 0.878

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

neurodegeneration | 2026-04-26 | 5 hypotheses Top: 0.712

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (12)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861]	["Han X", "Sun S", "Sun Y", "Song Q", "Z	Autophagy	2020	1
Interaction between autophagy and the NLRP3 inflammasome in Alzheimer's and Park [PMID:36262883]	Unknown	Frontiers in aging neuroscienc	2023	0
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438]	Hegdekar N, Sarkar C, Bustos S, Ritzel R	Autophagy	2023	0
Inflammasome assembly in neurodegenerative diseases. [PMID:37633753]	Singh J, Habean ML, Panicker N	Trends in neurosciences	2023	0
NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pat [PMID:34877938]	Li S, Sun Y, Song M, Song Y, Fang Y, Zha	JCI insight	2021	0
NLRP3 inflammasome activation drives tau pathology. [PMID:31748742]	["Ising C", "Venegas C", "Zhang S", "Sch	Nature	2019	0
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodeg [PMID:30381407]	Gordon R, Albornoz EA, Christie DC, Lang	Science translational medicine	2018	0
TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Prom [PMID:28817800]	["Mackenzie Ian R", "Nicholson Alexandra	Neuron	2017	0
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem prote [PMID:23455423]	Unknown	Nature	2013	0
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS [PMID:23254930]	Heneka MT, Kummer MP, Stutz A, Delekate	Nature	2013	0
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS [PMID:23254930]	["Heneka Michael T", "Kummer Markus P",	Nature	2013	0
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic latera [PMID:17023659]	Unknown	Science (New York, N.Y.)	2006	0

Debates (20)

Multi-agent debates referencing this entity

Structured research brief: Stathmin-2 Splice Switching to Prevent Axonal Degener

archived · Rounds: 2 · Score: 0.73 · 2026-04-28

How does N6-methyladenosine (m6A) RNA modification alter alpha-synuclein mRNA st

closed · Rounds: 4 · Score: 0.67 · 2026-04-28

Which proteogenomic network hubs identified by multi-omics PD studies are drugga

closed · Rounds: 4 · Score: 0.67 · 2026-04-28

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

closed · Rounds: 4 · Score: 0.65 · 2026-04-27

Debate: Interneuron SYNGAP1 Deficiency Disrupts Cortical Circuit Assembly During

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

closed · Rounds: 4 · Score: 0.87 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Related Research

Hypotheses and analyses mentioning protein in their description or question text

Stress-granule RNA-binding protein phase transition across ALS and FTD

Score: 0.780 · multi · 2026-04-28

Shared mechanism across ALS, FTD: Low-complexity RNA-binding proteins normally form reversible stress granules, but ALS/

TDP-43 Proteinopathy as a Cross-Disease Pathological Substrate

Score: 0.760 · neurodegeneration · 2026-04-28

TDP-43 misfolding and aggregation occurs as primary pathology in ALS/FTD (~95% and ~50% respectively) and as secondary p

ASO-mediated reduction of toxic C9orf72 dipeptide repeat proteins in ALS/FTD

Score: 0.760 · neurodegeneration · 2026-05-01

Antisense oligonucleotides targeting expanded GGGGCC repeats in C9orf72 offer the strongest therapeutic hypothesis by si

C9orf72 Hexanucleotide Repeat Dipeptide Repeat Proteins Inhibit Nucleocytoplasmi

Score: 0.738 · neurodegeneration · 2026-04-26

C9orf72 repeat transcripts undergo non-ATG translation producing DPRs (poly-GA, poly-GR, poly-PR) that sequester nucleoc

Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Blood as an Early Indi

Score: 0.735 · unknown disease · 2026-04-26

Elevated MMP-9/TIMP-1 ratio reflects net proteolytic activity against the BBB, causing degradation of tight junction pro

Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides

Score: 0.718 · neurodegeneration · 2026-04-02

## Mechanistic Overview Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides starts from the claim that modulating

Matrix Metalloproteinase-9/TIMP-1 Ratio in CSF Identifies Preclinical Tight Junc

Score: 0.675 · unknown disease · 2026-04-26

Matrix metalloproteinase-9 (MMP-9) degrades tight junction proteins (claudin-5, occludin, ZO-1) and extracellular matrix

J-protein co-chaperone repertoire enables selective recognition of pathogenic co

Score: 0.642 · protein-biochemistry · 2026-04-21

**Molecular Mechanism and Rationale** The J-protein co-chaperone system represents a sophisticated cellular quality con

Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Blood as an Early Indi

Score: 0.640 · unknown disease · 2026-04-26

Elevated MMP-9/TIMP-1 ratio reflects net proteolytic activity against the BBB, causing degradation of tight junction pro

Optogenetic PV Cell Activation Restores Gamma Power via PV Protein Upregulation

Score: 0.635 · alzheimers · 2026-04-28

Closed-loop stimulation of PV+ interneurons at gamma frequencies (40 Hz) using ChrimsonR rescues gamma oscillation power

Pericyte senescence is sufficient to weaken the BBB even without classic amyloid

Score: 0.630 · neurodegeneration · 2026-04-25

Selective induction of a senescence program in adult pericytes is sufficient to impair barrier-supportive trophic signal

ATXN2 Antisense Oligonucleotides Reduce Dipeptide Repeat Proteins in C9orf72-ALS

Score: 0.630 · neurodegeneration · 2026-05-10

ASO-mediated knockdown of ATXN2 reduces repeat-associated non-AUG translation of toxic dipeptide repeat proteins from C9

RNA-binding protein condensate maturation from reversible phase separation to am

Score: 0.626 · neurodegeneration · 2026-04-28

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a

protein

Understanding Entity Pages

Wiki Pages (21)

Amyloid Precursor Protein (APP)

APOC4 — Apolipoprotein C-IV

amyloid-beta-metalloproteinases

nf1-protein

nlrc5-protein

APOE — Apolipoprotein E

LRP1B — Low Density Lipoprotein Receptor-Related Protein 1B

IL1RAP — Interleukin-1 receptor accessory protein

atxn3-protein

Update TDP-43 protein page with comprehensive content

epas1-protein

tdp-43-fus-rna-proteinopathy-comparison

snca-protein

HNRNPG — Heterogeneous Nuclear Ribonucleoprotein G

fcgr2a-protein

proteinopathies-skin-neurodegenerative-disorders-nct06528964

CLU — Clusterin (Apolipoprotein J)

gnas-protein

heme-oxygenase-1-protein

rab3b-protein

dlgh2-protein

Outgoing (10)

Incoming (3)

Targeting Hypotheses (30)

Mentioning Analyses (30)

Proteogenomic Network Hubs as Druggable Targets in Early PD Neurodegeneration

m6A RNA Modification and Alpha-Synuclein Aggregation in Substantia Nigra

How does the intron-retained RNA isoform mechanistically reduce glucocerebrosida

What are the mechanisms by which microglial senescence contributes to ALS pathol

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

Which specific factors in conditioned medium from healthy astrocytes rescue moto

Does APOE4's reduced lipid-binding directly modulate SREBP2-SCAP complex retenti

Does Alectinib truly bind C1q directly with high affinity, or is this an experim

Does Alectinib truly bind C1q directly with high affinity, or is this an experim

Proteomics Differential Expression in AD CSF and Brain Tissue

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

Multi-modal Biomarker Panel Design for Early AD Detection

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

What are the specific PTM changes in synaptic vesicle proteins during early AD p

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

Quantitative proteomics of the aging synapse: protein turnover and aggregation i

How does engineered C. butyricum cross the blood-brain barrier to directly bind

How does SYNGAP1, a 'synaptic' protein, function in pre-synaptic radial glia cel

What molecular mechanisms explain how apoE promotes cerebral amyloid angiopathy

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

Does clusterin exacerbate or protect against neuronal death in neurodegeneration

What molecular mechanisms explain how KCNJ2 inhibition mitigates TBI-induced neu

How does PIKFYVE inhibition activate unconventional protein clearance via exocyt

What mechanisms explain how IDH1/IDH2 mutations with reduced enzymatic activity

RNA binding protein dysregulation across ALS FTD AD

Do SCFAs directly modulate α-synuclein aggregation in vivo at physiologically re

Extracellular vesicle biomarkers for early AD detection

What physicochemical properties determine selective protein recruitment vs exclu

What determines the selectivity and efficiency of intercellular transmission pat

What determines the specificity of DDR protein recruitment to dilncRNA-induced c

Experiments (0)

Related Papers (12)

Debates (20)

Structured research brief: Stathmin-2 Splice Switching to Prevent Axonal Degener

How does N6-methyladenosine (m6A) RNA modification alter alpha-synuclein mRNA st

Which proteogenomic network hubs identified by multi-omics PD studies are drugga

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

Debate: Interneuron SYNGAP1 Deficiency Disrupts Cortical Circuit Assembly During

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

Related Research

Stress-granule RNA-binding protein phase transition across ALS and FTD

TDP-43 Proteinopathy as a Cross-Disease Pathological Substrate

ASO-mediated reduction of toxic C9orf72 dipeptide repeat proteins in ALS/FTD

C9orf72 Hexanucleotide Repeat Dipeptide Repeat Proteins Inhibit Nucleocytoplasmi

Matrix Metalloproteinase-9 and TIMP-1 Ratio in Peripheral Blood as an Early Indi

Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides

Matrix Metalloproteinase-9/TIMP-1 Ratio in CSF Identifies Preclinical Tight Junc

J-protein co-chaperone repertoire enables selective recognition of pathogenic co